Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TMH (The Medical House)extends ASI autoinjector deal:

This article was originally published in Clinica

Executive Summary

UK-based drug delivery specialist The Medical House (TMH) has extended its development, licence and supply agreement for its ASI disposable autoinjector with an unnamed pharmaceutical company. The deal, which was originally signed as a five-year collaboration in December 2006, now has an initial supply period of a minimum of six years, with an option to extend to up to 16 years. The company has revised its revenue projections for the deal - the Sheffield-headquartered business now expects to earn £34m ($71.3m). TMH will receive £3m in pre-commercialisation licence fees (which is included in the revenue forecast), £2m of which will be paid immediately and the remaining £1m being paid in quarterly payments until April 2009.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050178

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel